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SUMMARY OF THE DISCUSSION ON MAMMARY CARCINOGENESIS IN THE RAT 
A.M.Kel1erer, University of Würzburg, Germany 
The discussion l e f t no doubt t h a t , even in t h i s specialized f i e l d of investiga­
ti o n s , there is no lack of experiments s t i l l to be performed, and no shortage 
of controversional i n t e r p r e t a t i o n and application of those results that are 
ava i1able. 
The f i r s t part was focussed on technical aspects, although the technical 
questions did largely r e f l e c t essential differences in approach and inter­
pre t a t i o n . Major topics were the problem of m u l t i p l i c i t y of mammary neoplasms 
and the decision to score f i r s t tumors only or a l l tumors in an animal. Closely 
related is the choice of the strategy either to remove a l l palpable lesions 
or to leave them in the animal for lat e r pathological assessment at necropsy. 
A further related point concerned the not uncommon observation of p a r t i a l and 
even complete regression of mammary neoplasms. This, in t u r n , led to the question, 
whether the pathological c l a s s i f i c a t i o n s have d i s t i n c t i n d i v i d u a l i t y or whether 
they are mere labels a f f i x e d to largely t r a n s i t i o n a l types of neoplasms. 
The second part of the discussion started out with considerations of terminology 
and of t e c h n i c a l i t i e s in the mathematical analysis. I t then addressed the 
wider question of the relevance of animal data to considerations of breast 
cancer in humans. The considerations were focussed on the r e l a t i v e biological 
effectiveness of neutrons at d i f f e r e n t dose levels and in rat strains of d i f f e r e n t 
spontaneous incidence. Particular a t t e n t i o n was given to the p o s s i b i l i t y that 
low incidences are associated with low neutron RBE and high spontaneous inci­
dences with high RBE. The subsequent resume aims at those points that found 
particular i n t e r e s t . 
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F i r s t part: The discussion started on an appropriate keynote with b r i e f 
inquiries exemplifying the nearly unlimited range of parameters to be varied, 
and ultimately to be understood, in radiation induced mammary neoplasia. Broerse 
pointed at the possible e f f e c t of a temporal reversal of DES-implantat ion and 
i r r a d i a t i o n ; Shellabarger reported that such reversal has indeed been studied 
in AC I rats and that certain effects - although no dramatic changes - have 
been seen. Paretzke emphazised the d e s i r a b i l i t y of information on the temporal 
dependence of tumor-growth rates and the interest in any variations with dose 
level or radiation q u a l i t y ; van Zwieten responded that the importance of the 
question had been appreciated in the experiment at TNO, but added that the 
analysis of the extensive data on tumor volumes was far from complete. 
A f a m i l i a r and recurrent topic in the study of mammary tumorigenesis in the 
rat was then considered. Gould posed the question whether f i r s t tumors only 
should be scored, in view of the common observation that animals with a previous 
neoplasm have a higher p r o b a b i l i t y for mammary tumors than animals without 
previous neoplasms. Van Zwieten concurred that the group at TNO derives 
actuarian incidences based on animals with tumor, regardless of the number 
of tumors. He added that multiple tumors, too, are registered and that their 
numbers are evaluated. There appeared to be agreement with the further state­
ment, that the increased pr o b a b i l i t y for subsequent tumors need not be caused 
by the f i r s t tumor; variations of inherent tumor rates within the s t r a i n , due 
for example to d i f f e r e n t hormonal status, would lead to the same r e s u l t . I f , 
however, the non-Poissonian d i s t r i b u t i o n of mammary fibromas or carcinomas is 
a r e f l e c t i o n of biological v a r i a b i l i t y among the s t r a i n , accounting for f i r s t 
tumors only would bias the investigation towards the lower tumor rates in the 
less susceptible i n d i v i d u a l s . Both the incidence based on f i r s t tumors only, 
and the cumulative tumor rate based on a l l tumors are therefore quantities of 
i nterest. 
This led to deliberations on the merits or disadvantages of removing pal­
pable lesions or leaving them in the animal u n t i l they reach a certain size 
or the animal dies. There was agreement that neither approach could provide 
a l l information. But there is also evident disagreement, as the large labora­
tories have chosen opposite approaches. 
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Van Zwieten commented on the procedure adopted at TNO not to remove a l l 
palpable lesions. This conservative procedure leads doubtlessly to a certain 
increase in the complexity of bookkeeping in a large experiment. The advantage 
is added information on tumor growth, and several participants of the dis­
cussion were intrigued by the not uncommonly observed regression or dis­
appearance of mammary carcinomas. In the current radiation experiments l i t t l e 
hard information on this point is obtained, and most of the regressing lesions 
could well be cysts. However, as Shellabarger emphasized, there is well estab­
lished evidence for regression of mammary adenocarcinomas a f t e r chemical car­
cinogenesis in the r a t . Adenocarcinomas tend to appear e a r l i e r then adeno-
fibromas, although averaged ever total l i f e time, t h e i r frequency is low. In 
pregnancy carcinomas tend to grow f a s t e r , but they frequently stop a f t e r lac-
tat i on. 
Barendsen raised the related point whether observed mammary neoplasms are 
pathologically d i s t i n c t , or whether they tend to be t r a n s i t i o n a l in type. He 
added the more general question whether transforming events are to be thought 
of as sp e c i f i c . Van Zwieten commented that there were c e r t a i n l y predominant 
patterns, but no clear-cut,stable types. Anaplastic tumors remain anaplastic, 
but most tumors dedifferentiate after repeated transplantation. 
A f i n a l point of interest was uniformity or non-uniformity of the frequency 
of tumors in d i f f e r e n t parts of the mammary tissue. With chemically induced 
adenocarcinomas there can be a substantially higher incidence in the anterior 
part of the mammary tissue. No similar observation has been made a f t e r uni­
form i r r a d i a t i o n . Shellabarger had ea r l i e r demonstrated the lack of an ab-
scopal e f f e c t ; an increased tumor incidence was found only in the irradiated 
mammary tissue of Sprague-Dawley r a t s , no change of the spontaneous incidences 
was observed in the shielded areas. Montour emphasized the d e s i r a b i l i t y and 
the potential of studies that would u t i l i z e heavy ions of properly chosen 
range and stopping power. Such studies could elucidate a number of factors 
that are not controlled in experiments with x-rays or neutrons. 
Second part: The discussion continued with considerations on terminology 
in the analysis of radiation carcinogenesis. There was consensus that competing 
risk corrected quantities had to be employed, but there appeared to be less 
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agreement on terminology. One proposal was to use the term nominal incidence 
for the competing ri s k corrected cumulative incidence up to a specified time. 
Another proposal, approved by several pa r t i c i p a n t s , was to u t i l i z e the term 
actuarian incidence. The considerations then turned to the more general aspects 
of s t a t i s t i c a l methodology. 
The ongoing study of mammary neoplasms at TNO permits, at present, only a 
p a r t i a l analysis, because the rats have longer tumor free l i f e spans than, 
for example, the Sprague-Dawley rats used by Shellabarger or by Vogel in the 
US. The attempt to draw meaningful conclusions from p a r t i a l results necessi­
tates the use of j o i n t f i t s to the various dose groups. As reported by Broerse, 
the notion of a forward s h i f t in time of the tumor incidences with increasing 
dose agrees well with the data. This is in line with previous findings of 
Shellabarger in Sprague-Dawley r a t s . Adequate f i t s were obtained by postulating 
power function in time for the tumor rates, and i t was emphasized that even 
such comparatively simple parametric solutions require computer analysis 
rather than visual f i t s . 
There is l i t t l e evidence from available observations that variation of more 
than one parameter is needed to represent the change in temporal dependencies 
of tumor rates after d i f f e r e n t doses of d i f f e r e n t radiations. Evidently this 
may be a matter of i n s u f f i c i e n t data. The question is therefore open. That 
i t has importance beyond the mere te c h n i c a l i t i e s of curve f i t t i n g was exem­
p l i f i e d by two further considerations in the discussion: 
- Mole stated that RBE values may well depend on the method of analysis, and 
could d i f f e r whether one asked for equal cumulative incidence up to a certain 
time, or for equality of the temporal d i s t r i b u t i o n of tumors. I f the change 
in temporal patterns a f t e r i r r a d i a t i o n is described by one single parameter 
modifying the response curves, equality of the parameter would imply equality 
of the entire response. One would then expect the same RBE values, regardless 
of the c r i t e r i o n chosen. I f , on the other hand, the radiation induced change 
is more complex, and requires the description by several parameters that may 
be affected d i f f e r e n t l y by d i f f e r e n t radiation q u a l i t i e s , the very concept 
of RBE would begin to be of doubtful a p p l i c a b i l i t y . 
- Gould emphasized that one must distinguish between mere changes in latency 
time, on the one hand, and actual increases of incidences, on the other hand. 
- 207 -
I t appears that better information w i l l be required to judge whether an 
acceleration in time, a forward s h i f t in time, or a time independent increase 
of tumor rates is the most suitable approximation to experimental observa­
ti o n s . I t was, furthermore, pointed out that tumor rates may vary as a power 
of time and t h a t , under this particular condition, an acceleration in time 
can not be distinguished from an increase of the tumor rates by a time inde­
pendent constant fa c t o r . 
Paretzke pointed out that a reasonably modest approach would focus on tumor 
incidences integrated over the l i f e span. However, he added, in agreement 
with Dennis and Mole, that the loss of l i f e time or of cancer free l i f e time 
is ultimately the more meaningful parameter for radiation protection. The 
more sophisticated considerations aimed at a qu a n t i f i c a t i o n of detriment 
are given particular attention in present investigations at GSF. 
Experimental studies in the rat and the mouse can, as reiterated by several 
p a r t i c i p a n t s , not be d i r e c t l y relevant to radiation protection and risk de­
termination in the sense of providing actual numerical values. Their potential 
value, as that of a l l animal studies, lies in the i d e n t i f i c a t i o n of recurrent 
t r a i t s and common characteristics of responses to d i f f e r e n t types of radiation 
and to d i f f e r e n t absorbed doses. The comparative study of d i f f e r e n t strains or 
stocks of animals was therefore an obvious focus of the discussion. 
No conclusion was reached on the cause of the s t r i k i n g difference in appearance 
times of tumors for the Sprague-Dawley rats used in the United States and in 
the Netherlands. A comparative study that included keeping the Dutch Sprague-
Dawley rats at Brookhaven, resulted in the same late appearance of tumors as 
observed at TNO. Van Bekkum pointed out that the later appearance of the 
mammary tumors is in line with a somewhat longer l i f e span of the Dutch stock. 
Greatly d i f f e r e n t values of the RBE of neutrons are found in d i f f e r e n t strains 
and even in the same strain with and without estrogen treatment. Various par­
ticipants expressed the opinion that high values of the RBE of neutrons are 
observed for adenofibromas, and generally for tumors with high spontaneous 
incidence. With low incidence of tumors - th i s was presumed to be the 
'physiological 1 condition - the RBE of neutrons tends to be low. 
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There was agreement that this is a question - i f not the question - of interest 
in the studies of mammary neoplasia in the r a t . But i t was pointed out that 
the association of high incidences with high neutron RBE and of low incidences 
with low RBE need not be inherent, although i t is commonly encountered. Animals 
with low incidence are generally less sensitive and require higher doses of 
any ionizing radiation for s t a t i s t i c a l l y meaningful results. At high neutron 
doses, however, the RBE is low, for fundamental biophysical reasons emphasized 
by Rossi. In animals with high incidence one can investigate small neutron 
doses, and the high RBE values reported by Vogel and by Shellabarger were ob­
tained under these conditions. 
In a recent experiment by Shellabarger on AC I r a t s , preimplanted with a 
r e l a t i v e l y high dose of DES, high incidences of adenocarcinomas were observed 
and the RBE of 430 keV neutrons was in excess of 100 at 0.01 Gy. At larger 
doses the RBE decreases, but at 0.09 Gy i t is s t i l l substantially larger than 10. 
On the other hand, the Sprague-Dawley rats with their high spontaneous incidence 
and their high RBE values at low doses show the same RBE of about 10 at doses 
close to 0.1 Gy as the non-DES treated AC I rats and other strains with low 
spontaneous incidence. 
Rossi expressed the opinion that meaningful differences in RBE for d i f f e r e n t 
strains can only be established on the basis of additional data. Many of the 
data reported at this conference were of preliminary nature, without the 
adequate error analysis that is required for d e f i n i t i v e conclusions. Based 
on available evidence the differences of RBE for mammary carcinogenesis at 
specified neutron energy and dose may well be within a factor of 2 in d i f f e r e n t 
s t r a i n s . He made the further point, that radiobiological observations are 
generally obtained at doses and at incidences beyond the acceptable levels 
in radiation protection. There is therefore every reason to expect that RBE 
values relevant to radiation protection w i l l be at least as large, and possibly 
much larger, than the values obtained in animal experiments with neutrons. 
Shellabarger concluded with the comment that the rat may, in many ways, be 
a poor model for man, but that differences between humans are equally s t r i k i n g . 
As Metalli cautioned, we do not know how relevant the studies on the rat are 
for risk estimates, but we know that comparative research is indispensable, 
and that i t must include animal experiments as well as human epidemiology. 
